Načítá se...
A rare IL33 loss-of-function mutation reduces blood eosinophil counts and protects from asthma
IL-33 is a tissue-derived cytokine that induces and amplifies eosinophilic inflammation and has emerged as a promising new drug target for asthma and allergic disease. Common variants at IL33 and IL1RL1, encoding the IL-33 receptor ST2, associate with eosinophil counts and asthma. Through whole-geno...
Uloženo v:
| Vydáno v: | PLoS Genet |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Public Library of Science
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5362243/ https://ncbi.nlm.nih.gov/pubmed/28273074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pgen.1006659 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|